Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Total
Balance, shares at Aug. 31, 2018 721,295        
Balance, amount at Aug. 31, 2018   $ 18,468,000 $ (26,223,000)   $ (7,755,000)
Warrants exercised for cash, amount   660,000     660,000
Warrants exercised for cash, shares 6,688        
Common stock issued for services rendered, amount   225,000     225,000
Common stock issued for services rendered, shares 2,990        
Stock-based compensation expense   154,000     154,000
Reclassification of derivative liability upon conversion of related convertible notes   12,000     12,000
Common stock issued upon conversion of convertible notes and interest, amount   8,839,000     8,839,000
Common stock issued upon conversion of convertible notes and interest, shares 101,679        
Inducement loss from debt conversion, amount   3,829,000     3,829,000
Inducement loss from debt conversion, shares 68,303        
Net Loss     (9,383,000)   (9,383,000)
Balance, shares at May. 31, 2019 900,955        
Balance, amount at May. 31, 2019   32,187,000 (35,606,000)   (3,419,000)
Balance, shares at Feb. 28, 2019 802,933        
Balance, amount at Feb. 28, 2019   25,846,000 (30,610,000)   (4,764,000)
Common stock issued for services rendered, amount   113,000     113,000
Common stock issued for services rendered, shares 2,024        
Stock-based compensation expense   (5,000)     (5,000)
Reclassification of derivative liability upon conversion of related convertible notes   12,000     12,000
Common stock issued upon conversion of convertible notes and interest, amount   3,948,000     3,948,000
Common stock issued upon conversion of convertible notes and interest, shares 52,211        
Inducement loss from debt conversion, amount   2,273,000     2,273,000
Inducement loss from debt conversion, shares 43,787        
Net Loss     (4,996,000)   (4,996,000)
Balance, shares at May. 31, 2019 900,955        
Balance, amount at May. 31, 2019   32,187,000 (35,606,000)   (3,419,000)
Balance, shares at Aug. 31, 2019 909,222        
Balance, amount at Aug. 31, 2019   32,505,000 (44,950,000) $ (325,000) (12,770,000)
Common stock issued for services rendered, amount   75,000     75,000
Common stock issued for services rendered, shares 856        
Stock-based compensation expense   745,000     745,000
Common stock issued for warrant exercise, shares 6,275        
Common stock issued for warrant exercise   33,000     33,000
Treasury Stock retired, amount   (325,000)   $ 325,000  
Treasury Stock retired, shares (13,953)        
Common stock issued for note exchange   200,000     200,000
Shares issued for debt conversion 21,750        
Common stock issued upon conversion of convertible notes and interest, amount   6,238,000     6,238,000
Common stock issued upon conversion of convertible notes and interest, shares 589,695        
Common stock issued for underwritten offering, net of offering costs   10,332,000     10,332,000
Common stock issued for underwritten offering, net of offering costs, shares 2,222,160        
Common stock issued for warrant exchange   552,000     552,000
Common stock issued for warrant exchange, shares 82,653        
Allocated fair value of beneficial conversion feature - exchanged notes payable   653,000     653,000
Allocated fair value of warrants issued - exchanged notes payable   2,006,000     2,006,000
Reclassification of derivative liabilities to paid in capital   1,979,000     1,979,000
Inducement loss on note conversions, amount   624,000     624,000
Inducement loss on note conversions, shares 38,658        
Modification of warrants   22,000     22,000
Expense related to preferred options   62,091,000     62,091,000
Net Loss     (66,289,000)   (66,289,000)
Balance, shares at May. 31, 2020 3,857,316        
Balance, amount at May. 31, 2020   117,730,000 (111,239,000)   6,491,000
Balance, shares at Feb. 29, 2020 1,103,643        
Balance, amount at Feb. 29, 2020   37,620,000 (38,061,000)   (441,000)
Stock-based compensation expense   75,000     75,000
Common stock issued for warrant exercise, shares 6,275        
Common stock issued for warrant exercise   33,000     33,000
Common stock issued upon conversion of convertible notes and interest, amount   4,023,000     4,023,000
Common stock issued upon conversion of convertible notes and interest, shares 441,573        
Common stock issued for underwritten offering, net of offering costs   10,332,000     10,332,000
Common stock issued for underwritten offering, net of offering costs, shares 2,222,160        
Common stock issued for warrant exchange   552,000     552,000
Common stock issued for warrant exchange, shares 82,653        
Allocated fair value of beneficial conversion feature - exchanged notes payable   653,000     653,000
Allocated fair value of warrants issued - exchanged notes payable   2,006,000     2,006,000
Reclassification of derivative liabilities to paid in capital   288,000     288,000
Inducement loss on note conversions, amount   57,000     57,000
Inducement loss on note conversions, shares 1,012        
Expense related to preferred options   62,091,000     62,091,000
Net Loss     (73,178,000)   (73,178,000)
Balance, shares at May. 31, 2020 3,857,316        
Balance, amount at May. 31, 2020   $ 117,730,000 $ (111,239,000)   $ 6,491,000